Ensuring that safe blood and tissue products are available when they are needed is important to the health and wellbeing of Americans. The Office of Infectious Disease and HIV/AIDS Policy (OIDP) coordinates HHS activities related to blood and tissue safety and availability.
- Executive Summary of the 2022 NHLBI and OASH State of the Science in Transfusion Medicine Symposium*
- Findings from the 2019 National Blood Collection and Utilization Survey
- CDC Interim Infection Control Guidance for Blood and Plasma Collection
- Request for Information: Regarding a Revision to U.S. Public Health Service Guideline: Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection
*People using assistive technology may not be able to fully access information in these files. For assistance, contact the HHS Office of Infectious Disease Policy at 202-795-7697 or by emailing email@example.com.